0001209191-20-006387.txt : 20200204
0001209191-20-006387.hdr.sgml : 20200204
20200204163758
ACCESSION NUMBER: 0001209191-20-006387
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200204
FILED AS OF DATE: 20200204
DATE AS OF CHANGE: 20200204
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DUNLEVIE BRUCE
CENTRAL INDEX KEY: 0001190211
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39203
FILM NUMBER: 20574322
MAIL ADDRESS:
STREET 1: 2480 SAND HILL ROAD
STREET 2: SUITE 200
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: 1Life Healthcare Inc
CENTRAL INDEX KEY: 0001404123
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
IRS NUMBER: 760707204
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE EMBARCADERO CENTER, SUITE 1900
CITY: San Francisco
STATE: CA
ZIP: 94111
BUSINESS PHONE: 415-658-6792
MAIL ADDRESS:
STREET 1: ONE EMBARCADERO CENTER, SUITE 1900
CITY: San Francisco
STATE: CA
ZIP: 94111
FORMER COMPANY:
FORMER CONFORMED NAME: 1life Healthcare Inc
DATE OF NAME CHANGE: 20070621
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-04
0
0001404123
1Life Healthcare Inc
ONEM
0001190211
DUNLEVIE BRUCE
C/O BENCHMARK
2965 WOODSIDE ROAD
WOODSIDE
CA
94062
1
0
1
0
Common Stock
2020-02-04
4
C
0
5749630
A
5936630
I
See Footnote
Common Stock
2020-02-04
4
C
0
3736192
A
9672822
I
See Footnote
Common Stock
2020-02-04
4
C
0
3046168
A
12718990
I
See Footnote
Common Stock
2020-02-04
4
C
0
679393
A
13398383
I
See Footnote
Common Stock
2020-02-04
4
C
0
220217
A
13618600
I
See Footnote
Series B Preferred Stock
2020-02-04
4
C
0
5749630
0.00
D
Common Stock
5749630
0
I
See Footnote
Series C Preferred Stock
2020-02-04
4
C
0
3736192
0.00
D
Common Stock
3736192
0
I
See Footnote
Series D Preferred Stock
2020-02-04
4
C
0
3046168
0.00
D
Common Stock
3046168
0
I
See Footnote
Series E Preferred Stock
2020-02-04
4
C
0
679393
0.00
D
Common Stock
679393
0
I
See Footnote
Series G Preferred Stock
2020-02-04
4
C
0
220217
0.00
D
Common Stock
220217
0
I
See Footnote
Warrant (Right to Buy)
6.5858
2020-02-04
4
C
0
11010
0.00
D
2020-10-03
Series G Preferred Stock
11010
0
I
See Footnote
Warrant (Right to Buy)
6.5858
2020-02-04
4
C
0
11010
0.00
A
2020-10-03
Common Stock
11010
11010
I
See Footnote
Each share of Issuer's Preferred Stock automatically converted into an equal number of shares of Issuer's Common Stock upon the closing of the Issuer's initial public offering and has no expiration date.
Securities held by Benchmark Capital Partners V, L.P. ("BCP V"), as nominee for BCP V, Benchmark Founders' Fund V, L.P. ("BFF V"), Benchmark Founders' Fund V-A, L.P. ("BFF V-A"), Benchmark Founders' Fund V-B, L.P. ("BFF V-B"), and related individuals. Benchmark Capital Management Co. V, L.L.C. ("BCMC V"), the general partner of BCP V, BFF V, BFF V-A and BFF V-B, may be deemed to have sole voting and dispositive power over the securities. Bruce W. Dunlevie, a member of the Issuer's board of directors, Alexandre Balkanski, Peter H. Fenton, J. William Gurley, Kevin R. Harvey, Robert C. Kagle, Mitchell H. Lasky and Steven M. Spurlock are the managing members of BCMC V, and each of them may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims the existence of a "group" and disclaims beneficial ownership of the securities, except to the extent of such person or entity's pecuniary interest in such securities.
Shares subject to the warrant are immediately exercisable.
This report is one of three reports, each on a separate Form 4, but relating to the same holdings being filed by entities affiliated with Benchmark and their applicable members.
/s/ Steven M. Spurlock, by power of attorney for Bruce W. Dunlevie
2020-02-04